Alternative splicing—the way cells edit gene messages—forms a second, independent layer of lifespan control across mammals, with distinctive patterns in long‑lived species, especially in the brain.
ahmadzada on Freepik
The upper limit of how long a human being can live may depend on which genes are active and how cells edit the instructions those genes produce. A recent study of mammals reveals that a process called alternative splicing varies in precise, predictable ways between short-lived and long-lived species. The finding identifies an entirely new biological axis of lifespan regulation. It operates independently of the gene expression changes that have been studied for decades, and may eventually point toward interventions for age-related disease.
The molecular machinery that determines a species’ lifespan is not fixed in a single layer of biology. It is distributed across at least two: gene activity and gene editing. The editing layer is only now coming into focus.
Every human gene can produce multiple versions of its protein product. The process responsible for this is called alternative splicing. After a gene is copied into a preliminary RNA message, the cell’s machinery selects which segments to keep and which to cut out before assembling the final instruction set. These segments, called exons, are the parts of a gene that actually code for pieces of the protein.
Think of them like Lego bricks, with each one representing a small section that contributes to the final build. From the same set of Legos, you might create different structures by choosing different combinations of pieces. In the same way, a cell can join different exons together to form distinct versions of a protein, known as isoforms, each with its own shape and function.
Up to 95% of human genes with multiple segments undergo this editing. The result is an expansion of protein diversity from a finite number of genes. This has long been linked to disease. Roughly 15% of hereditary conditions and cancers involve splicing errors. What remains unclear is whether splicing patterns differ systematically across species with different maximum lifespans and whether those differences carry biological meaning.
The recent study analyzed splicing patterns across six tissues: brain, heart, kidney, liver, lung and skin. It focused on 26 mammalian species with lifespans ranging from just over 2 years to 37 years. They identified 731 splicing events whose patterns correlate with maximum lifespan. About half of long-lived species show increased exon numbers, parts of genes that code for proteins. The other half shows the opposite.
These splicing events are largely distinct from the genes whose overall expression levels correlate with lifespan. Splicing captures lifespan-related information that standard gene activity measurements miss entirely. The two layers of regulation, transcription and splicing, operate in parallel, each encoding different aspects of what makes one species long-lived and another short-lived.
In most tissues, lifespan and body mass are closely intertwined. The brain’s splicing patterns break from this constraint. It maintains a distinct splicing program tied to the species' survival time. The brain contains two to three times more lifespan-associated splicing events unique to a single tissue than any other organ. Genes involved in how brain cells communicate and change, such as those that help form connections between neurons, build nerve fibers and release chemical signals, make up over 15% of the main groups found among genes whose splicing is linked to lifespan.
The study does not deliver a therapy. It delivers a map. The genes, pathways, and regulatory proteins it identifies constitute a network of potential targets for interventions aimed at extending healthy lifespan. The enrichment of lifespan-associated splicing in protein regions that confer molecular flexibility suggests that long-lived species may maintain their cells’ ability to adapt to stress and metabolic challenge through splicing-level fine-tuning.
For the growing population of people living into their eighties and nineties with accumulating chronic disease, this work reframes a fundamental question. Aging is not only about which genes turn on or off. It is about how cells edit the messages those genes send, and whether that editing can be guided toward the patterns that nature has already selected for longer life.
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。